Sandoz Canada Inc. C/O UPS SCS Pharmaceutical Import Profile — Canada (DGFT 2022–2026)

Name: Sandoz Canada Inc. C/O UPS SCS Pharmaceutical Import Records from India — 3 Products, $5.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Sandoz Canada Inc. C/O UPS SCS — Pharmaceutical Importer Profile (2026) | 3 Products, $5.5M Trade | TransData Nexus

Sandoz Canada Inc. C/O UPS SCS

Pharmaceutical Importer · Canada · Diabetes & Endocrine Focus · $5.5M Total Trade · DGFT Verified

Sandoz Canada Inc. C/O UPS SCS is a pharmaceutical importer based in Canada with a total trade value of $5.5M across 3 products in 3 therapeutic categories. Based on 125 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Sandoz Canada Inc. C/O UPS SCS sources from 3 verified Indian suppliers, with Sandoz Private Limited accounting for 71.3% of imports.

Sandoz Canada Inc. C/O UPS SCS — Import Portfolio & Supplier Network

Sandoz Canada Inc. C/O UPS SCS import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Sandoz Canada Inc. C/O UPS SCS?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sandoz Private Limited	$13.8M	368	71.3%
Alembic Pharmaceuticals Limited	$5.3M	203	27.6%
Intas Pharmaceuticals Limited

What Formulations Does Sandoz Canada Inc. C/O UPS SCS Import?

Formulation	Value	Ships
Material no. - 44100995 sitaglip+metf	$544.9K	13
Sitaglip+metf sdz 50+1000MG 360fct bo	$335.2K	7
Sitaglip+metf sdz 50+1000MG 60prt bo camaterial no. -	$321.1K	7
Material no. - 44100861 sitaglip+metf	$300.0K	6
Material no- 44100995 sitaglip+metf sdz50+1000MG 360fct bo	$280.4K	6
Sitaglip+metf sdz 50+1000MG 360fct bo camaterial no. -	$280.1K	6
Material no-44100966 sitaglip+metf sdz 50+1000MG 60fct bo	$276.3K	6
Tacrolimus sdz 1MG 100hgc bo ca	$250.0K	5
Tacrolimus sdz 1MG 100hgc bo ca materialno. -	$250.0K	5
Duloxetine CAPS. 60 MG ( duloxetine cap60mg 100c_sivem cn	$249.8K	6
Sandoz duloxetine CAPS 30MG	$244.4K	5
Material no. - 44100966 sitaglip+metf	$227.7K	6
Mycophenolate 250MG 50hgc v1 ca materialno. -	$201.7K	6
Sitagliptin sdz 100MG 100fct bo ca	$200.0K	4
Sitaglip+metf sdz 50+1000MG 60prt bo camaterial no. -	$200.0K	4

Sandoz Canada Inc. C/O UPS SCS imports 323 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Sitagliptin	Diabetes & Endocrine	$3.0M	61	4.0%	3
2	Tacrolimus	Immunosuppressants	$1.6M	33	0.8%	10
3	Dapagliflozin	Advanced Diabetes Medications	$823.5K	31	1.7%	14

Sandoz Canada Inc. C/O UPS SCS imports 3 pharmaceutical products across 3 categories into Canada totaling $5.5M.

Sandoz Canada Inc. C/O UPS SCS — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Sandoz Canada Inc. C/O UPS SCS is a pharmaceutical importer and buyer operating within the Canadian market. The company is headquartered in Canada and functions as a key player in the distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. By leveraging UPS Supply Chain Solutions (UPS SCS), Sandoz Canada Inc. enhances its logistics and distribution capabilities, ensuring efficient delivery of pharmaceutical products across the country. This strategic partnership underscores the company's commitment to maintaining a robust supply chain and meeting the diverse needs of the Canadian healthcare sector.

2Distribution Network

Sandoz Canada Inc. operates a comprehensive distribution network facilitated by its collaboration with UPS SCS. This partnership enables the company to manage an extensive logistics operation, ensuring timely and efficient delivery of pharmaceutical products throughout Canada. While specific warehouse locations are not publicly disclosed, the integration with UPS SCS suggests a well-established infrastructure capable of supporting nationwide distribution. The company's logistics capabilities are designed to meet the demands of the Canadian market, ensuring that healthcare providers have access to essential medications when needed.

3Industry Role

In Canada's pharmaceutical supply chain, Sandoz Canada Inc. C/O UPS SCS serves primarily as a pharmaceutical importer and distributor. The company focuses on sourcing finished pharmaceutical formulations from international suppliers, particularly from India, and facilitating their entry into the Canadian market. By importing a diverse range of pharmaceutical products, Sandoz Canada Inc. plays a crucial role in enhancing the availability and accessibility of medications within Canada. This position allows the company to contribute significantly to the healthcare sector by ensuring a steady supply of essential drugs to meet the needs of Canadian patients.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Sandoz Canada Inc. C/O UPS SCS

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Sandoz Canada Inc. exhibits a high degree of sourcing concentration, with 71.3% of its total import value from India attributed to Sandoz Private Limited. This significant reliance on a single supplier indicates a strategic choice aimed at ensuring consistent product quality and supply chain stability. However, such concentration also introduces potential risks, including vulnerability to supply disruptions or changes in supplier dynamics. The company's decision to source a substantial portion of its imports from Sandoz Private Limited suggests a strong partnership and trust in the supplier's capabilities. Nonetheless, it is essential for Sandoz Canada Inc. to monitor and manage these risks to maintain a resilient supply chain.

2Supply Chain Resilience

Sandoz Canada Inc.'s supply chain resilience is closely tied to its sourcing strategy, particularly its reliance on Sandoz Private Limited for a significant portion of its imports. While this concentration can lead to efficiencies and strong supplier relationships, it also exposes the company to potential risks such as supply disruptions or geopolitical challenges affecting the supplier's operations. The company's limited engagement with other suppliers, such as Alembic Pharmaceuticals Limited and Intas Pharmaceuticals Limited, suggests a focused sourcing approach. To enhance supply chain resilience, Sandoz Canada Inc. may consider diversifying its supplier base and establishing contingency plans to mitigate potential disruptions.

Importing Pharmaceuticals into Canada — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Canada

1Regulatory Authority & Framework

In Canada, the regulation of pharmaceutical imports is overseen by Health Canada, the federal department responsible for national public health. The primary legislation governing pharmaceutical imports is the Food and Drugs Act, along with its associated regulations, including the Food and Drug Regulations. These regulations establish the requirements for the importation, sale, and distribution of drugs within Canada, ensuring that all pharmaceutical products meet the necessary standards for safety, efficacy, and quality. Health Canada's role is to enforce these regulations, conduct inspections, and provide guidance to importers to maintain compliance with Canadian health standards.

2Import Licensing & GMP

Importers of pharmaceutical products into Canada must hold an Establishment Licence (EL) issued by Health Canada. This licence authorizes the importer to conduct specific activities, including the importation of drugs. Additionally, the foreign manufacturing site must be listed on the importer's EL, ensuring that the source of the pharmaceutical products complies with Canadian regulatory standards. Good Manufacturing Practices (GMP) certification is also a critical requirement. Health Canada recognizes GMP certifications from reputable authorities, such as the European Union (EU) GMP, World Health Organization (WHO) GMP, and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications attest to the manufacturing quality and safety of pharmaceutical products, which is essential for their approval and sale in the Canadian market.

Sandoz Canada Inc. C/O UPS SCS — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Sandoz Canada Inc. focuses its product strategy on three primary therapeutic categories: Diabetes & Endocrine, Immunosuppressants, and Advanced Diabetes Medications. This focus aligns with the company's import portfolio, where the top three products—Sitagliptin, Tacrolimus, and Dapagliflozin—are central to these categories. The decision to concentrate on these therapeutic areas is likely driven by the significant demand for treatments in these fields within the Canadian healthcare system. By importing a diverse range of products within these categories, Sandoz Canada Inc. aims to meet the evolving needs of patients and healthcare providers, ensuring access to essential medications that address prevalent health conditions.

2Sourcing Profile

Sandoz Canada Inc. employs a sourcing strategy that emphasizes the importation of finished pharmaceutical formulations from India. This approach allows the company to offer a wide array of products without the complexities associated with manufacturing. The focus on finished formulations ensures that the products are ready for distribution and use, aligning with the company's role as a distributor in the Canadian market. India's established pharmaceutical manufacturing industry, known for its adherence to international quality standards, makes it a strategic sourcing partner for Sandoz Canada Inc. This sourcing strategy enables the company to provide high-quality medications to meet the needs of the Canadian healthcare sector.

Seller's Guide — How to Become a Supplier to Sandoz Canada Inc. C/O UPS SCS

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Sandoz Canada Inc., particularly in the therapeutic categories of Diabetes & Endocrine, Immunosuppressants, and Advanced Diabetes Medications. The company's current sourcing pattern indicates a reliance on a limited number of suppliers, suggesting potential gaps that new suppliers could fill. By offering high-quality products that meet Health Canada's regulatory standards, new Indian suppliers can position themselves as valuable partners to Sandoz Canada Inc., contributing to the diversification and resilience of the company's supply chain.

2Requirements & Qualifications

Indian exporters seeking to supply Sandoz Canada Inc. must ensure that their products comply with Health Canada's regulatory requirements. This includes obtaining the necessary Good Manufacturing Practices (GMP) certifications recognized by Health Canada, such as EU GMP, WHO GMP, or PIC/S. Additionally, the foreign manufacturing site must be listed on the importer's Establishment Licence (EL). Products must also meet Health Canada's quality and labeling standards, including batch testing, stability requirements, and bilingual labeling in English and French. Ensuring compliance with these standards is essential for successful market entry into Canada.

Frequently Asked Questions — Sandoz Canada Inc. C/O UPS SCS

What products does Sandoz Canada Inc. C/O UPS SCS import from India?

Sandoz Canada Inc. C/O UPS SCS imports 3 pharmaceutical products across 3 categories. Top imports: Sitagliptin ($3.0M), Tacrolimus ($1.6M), Dapagliflozin ($823.5K).

Who supplies pharmaceuticals to Sandoz Canada Inc. C/O UPS SCS from India?

Sandoz Canada Inc. C/O UPS SCS sources from 3 verified Indian suppliers. The primary supplier is Sandoz Private Limited (71.3% of imports, $13.8M).

What is Sandoz Canada Inc. C/O UPS SCS's total pharmaceutical import value?

Sandoz Canada Inc. C/O UPS SCS's total pharmaceutical import value from India is $5.5M, based on 125 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Sandoz Canada Inc. C/O UPS SCS focus on?

Sandoz Canada Inc. C/O UPS SCS imports across 3 categories. The largest: Diabetes & Endocrine (55.2%), Immunosuppressants (29.9%), Advanced Diabetes Medications (14.9%).

Get Full Sandoz Canada Inc. C/O UPS SCS Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Sandoz Canada Inc. C/O UPS SCS

Sandoz Canada Inc. C/O UPS SCS — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Sandoz Canada Inc. C/O UPS SCS?

What Formulations Does Sandoz Canada Inc. C/O UPS SCS Import?

What Products Does Sandoz Canada Inc. C/O UPS SCS Import?

Top Products by Import Value

Sandoz Canada Inc. C/O UPS SCS Therapeutic Categories — 3 Specializations